GlassScriptPhysician profile
Jennifer A Gorham
NPI 1508251042
$5,153.29
in general payments reported to CMS, 2019-2025
21 companies · $18.91 in 2025
The $18.91 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,101 · 2022: $2,078 · 2023: $1,937 · 2024: $17.96 · 2025: $18.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,974.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,974.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,611.61 | 2021-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $800.71 | 2021-2024 | Xifaxan, Trulance |
| Janssen Biotech, INC. | $581.37 | 2021-2023 | Stelara |
| Celgene Corporation | $363.10 | 2021-2023 | Zeposia |
| Takeda Pharmaceuticals U.S.A., INC. | $335.12 | 2021-2023 | Entyvio, Gattex |
| Amgen INC. | $328.74 | 2021-2023 | Avsola, Amjevita |
| Genzyme Corporation | $170.47 | 2022-2023 | |
| Pfizer INC. | $150.25 | 2022-2023 | |
| Boston Scientific Corporation | $136.49 | 2023 | Watchman |
| Braintree Laboratories, INC. | $98.40 | 2021-2022 | |
| Organon LLC | $88.31 | 2023 | Renflexis, Hadlima |
| Qol Medical, LLC | $79.53 | 2022-2023 | Sucraid |
| Nestle Healthcare Nutrition INC. | $67.17 | 2021-2023 | |
| Redhill Biopharma INC. | $65.66 | 2021-2023 | Movantik, Talicia |
| Ironwood Pharmaceuticals, INC | $62.85 | 2021-2023 | Linzess |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $54.50 | 2021-2023 | Dificid |
| Ardelyx, INC. | $49.62 | 2022 | |
| Intercept Pharmaceuticals, INC. | $45.85 | 2022-2023 | Ocaliva |
| Ferring Pharmaceuticals INC. | $29.54 | 2021-2022 | |
| Abbott Laboratories | $18.91 | 2025 | Ensite |
| Fresenius Kabi USA, LLC | $15.09 | 2023 | Idacio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Gorham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.